Residual thyroid tissue after thyroidectomy in a patient with TSH receptor-activating mutation presenting as a neck mass

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 2, 2013, Pages 448-452

  Singer, Kanakadurga ^a,b   Menon, Ram K ^a   Lesperance, Marci M ^a   McHugh, Jonathan B ^a   Gebarski, Stephen S ^a   Avram, Anca M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CALCITRIOL; CALCIUM CARBONATE; IODINE 123; LEVOTHYROXINE; LUGOL; PHENOBARBITAL; PROPRANOLOL; PROPYLTHIOURACIL; THYROTROPIN RECEPTOR; URSODEOXYCHOLIC ACID;

ARTICLE; CANCER RISK; CANCER SURGERY; CASE REPORT; CHILD; CLINICAL EVALUATION; DNA DETERMINATION; ECTOPIC THYROID GLAND; FOLLOW UP; HEPATOMEGALY; HUMAN; HYPERBILIRUBINEMIA; HYPOPARATHYROIDISM; HYPOTHYROIDISM; IMAGE ANALYSIS; LARYNGOSCOPY; MALE; MUTATIONAL ANALYSIS; NECK TUMOR; NERVOUSNESS; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SLEEP DISORDER; THYROID FOLLICLE CELL; THYROID FUNCTION TEST; THYROIDECTOMY; THYROTOXICOSIS; TUMOR ABLATION; TYMPANOSTOMY TUBE; VOCAL CORD PARALYSIS; WEIGHT GAIN;

CHILD; HUMANS; MALE; MUTATION; RECEPTORS, THYROTROPIN; THYROID GLAND; THYROID NODULE; THYROIDECTOMY;

EID: 84873630370     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3146     Document Type: Article

References (19)

1. Kopp P. The TSH receptor and its role in thyroid disease. Cell Mol Life Sci. 2001;58:1301-1322.
2. Aycan Z, A∂́ladýo∂́lu SY, Ceylaner S, Cetinkaya S, Bap VN, Kendirici HN. Sporadic nonautoimmune neonatal hyperthyroidism due to A623V germline mutation in the thyrotropin receptor gene. J Clin Res Pediatr Endocrinol. 2010;2:168-172.
3. Chester J, Rotenstein D, Ringkananont U, et al. Congenital neonatal hyperthyroidism caused by germline mutations in the TSH receptor gene. J Pediatr Endocrinol Metab. 2008;21:479-486.
4. Polak M. Hyperthyroidism in early infancy: pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism. Thyroid. 1998;8:1171-1177.
5. Watkins MG, Dejkhamron P, Huo J, Vazquez DM, Menon RK. Persistent neonatal thyrotoxicosis in a neonate secondary to a rare thyroid-stimulating hormone receptor activating mutation: case report and literature review. Endocr Pract. 2008;14:479-483.
6. Duprez L, Parma J, Van Sande J, Allgeier A, Leclère J, Schvartz C, et al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet. 1994;7:396-401.
7. Tonacchera M, Agretti P, Rosellini V, Ceccarini G, Perri A, Zampolli M. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene. Thyroid. 2000;10:859-863.
8. Bö rgel K, Pohlenz J, Koch HG, Bramswig JH. Long-term carbimazole treatment of neonatal nonautoimmune hyperthyroidism due to a new activating TSH receptor gene mutation (Ala428Val). Horm Res. 2005;64:203-208.
9. Karges B, Krause G, Homoki J, Debatin KM, de Roux N, Karges W. TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5. J Endocrinol. 2005;186:377-385.
10. Claus M, Maier J, Paschke R, Kujat C, Stumvoll M, Fü hrer D. Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism. Thyroid. 2005;15:1089-1094.
11. Elgadi A, Arvidsson CG, Janson A, Marcus C, Costagliola S, Norgren S. Autosomal-dominant non-autoimmune hyperthyroidism presenting with neuromuscular symptoms. Acta Paediatr. 2005;94: 1145-1148.
12. Biebermann H, Schö neberg T, Hess C, Germak J, Gudermann T, Grü ters A. The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism. J Clin Endocrinol Metab. 2001;86:4429-4433.
13. Nwosu BU, Gourgiotis L, Gershengorn MC, Neumann S. A novel activating mutation in transmembrane helix 6 of the thyrotropin receptor as cause of hereditary nonautoimmune hyperthyroidism. Thyroid. 2006;16:505-512.
14. Pohlenz J, Pfarr N, Krü ger S, Hesse V. Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R). Acta Paediatr. 2006;95:1685-1687.
15. Tonacchera M, Van Sande J, Cetani F, et al. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab. 1996;81:547-554.
16. Bircan R, Miehle K, Mladenova G, et al. Multiple relapses of hyperthyroidism after thyroid surgeries in a patient with long term follow-up of sporadic non-autoimmune hyperthyroidism. Exp Clin Endocrinol Diabetes. 2008;116:341-346.
17. Sharlin DS, Visser TJ, Forrest D. Developmental and cell-specific expression of thyroid hormone transporters in the mouse cochlea. Endocrinology. 2011;152:5053-5064.
18. Freeman S, Cherny L, Sohmer H. Thyroxine affects physiological and morphological development of the ear. Hear Res. 1996;97: 19-29.
19. Gujar S. Dehiscent jugular bulb. In: Hoeffner EG, Mukherji SK, Gandhi D, Gomez-Hassan D, Guchar S, Ibrahim M, Parmar H, eds. Temporal Bone Imaging. New York, NY: Thieme Medical Publishers, Inc.; 2008:61-62.